the aid library

LIST OPTIONS

Filter

704

Cadre de l'Assurance Qualité Test de Diagnostic Rapide de l'Antigene COV-2-SARS
recommended

African Union; Africa CDC Centres for Disease Control and Prevention; AMREF; ASLM; et al. (2021) CC

ASLM in collaboration with the Africa Centres for Disease Control and Prevention, and in partnership with the Clinton Health Access Initiative, Amref and Last Mile Health present the Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19. This framework aims to pr... more

Download (268)

View PDF (354)

Infection Prevention and Control (IPC) Standard Operating Procedure (SOP) for Training/Meetings in the context of COVID-19
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2022) CC

1.0 PURPOSE To define the procedure for the conduct of in-person meetings in both healthcare and community settings in response to COVID-19 and with respect to Public Health and Social Measures (PHSMs) to reduce the risk of disease transmission. A general risk assessment must be conducted to inform... more

Download (500)

View PDF (853)

Job aid: How to do the rapid test to detect G6PD deficiency

World Health Organization WHO (2018) C_WHO

Download (291)

View PDF (313)

Quality and safety practices for malaria rapid testing services

World Health Organization WHO (2022) C_WHO

This document is a guide defining requirements for quality and safety for malaria rapid diagnostic testing services to safeguard the quality of the results, the safety of the operators and patients and that of the environment for use by national malaria control programmes, regulators, implementers a... more

Download (498)

View PDF (619)

Critères de choix recommandés pour l’achat de tests de diagnostic rapide du paludisme

Organisation Mondiale de la Santé OMS (2019) C_WHO

External Link

Learning how to use the COVID-19 Vaccine Introduction and deployment Costing (CVIC) tool

Open WHO; World Health Organization WHO (2021) C_WHO

The CVIC tool is the WHO-UNICEF tool designed to assist countries in the process of planning and costing COVID-19 vaccination. The aim of this course is to demonstrate the use of the CVIC tool. The course is targeting national programme managers and personnel who have been involved in the costing, b... more

External Link

How to safely collect pus samples from buboes of patients suspected to be infected with bubonic plague

World Health Organization WHO (2016) C_WHO

Interim Guidance

Download (454)

View PDF (969)

New technology allows for rapid diagnosis of Ebola in the Democratic Republic of the Congo

World Health Organization WHO (2017)

Download (195)

View PDF (232)

Developmental roadmap for antimicrobial susceptibility testing systems

Belkum, A.van, T. T. Bachmann, G. Lüdke, et al. (2019) CC

Nature Reviews Microbiology Vol. 17 (2019)pp.51-62 Antimicrobial susceptibility testing (AST) technologies help to accelerate the initiation of targeted antimicrobial therapy for patients with infections and could potentially extend the lifespan of current narrow- spectrum antimicrobials. Althoug... more

Download (407)

View PDF (904)

Liberia MIS 2016 Malaria Fact Sheet

National Malaria Control Program Ministry of Health (MOH), The DHS Program (2017) C2

Download (224)

View PDF (310)

Utafiti wa Viashiria vya Malaria Tanzania (TMIS) 2017

The DHS Program (2018) CC

Tanzania Malaria Indicator Survey

Download (168)

View PDF (262)

2017 Tanzania Malaria Indicator Survey (TMIS)

The DHS Program (2018) CC

Download (218)

View PDF (247)

COVID-19 clinical care pathway (‎CARE)‎: confirm SARS-CoV-2 infection, assess symptoms, risk factors and severity, respond with appropriate care and treatment, evaluate clinical response and recovery

World Health Organization WHO (2022) CC

The COVID-19 CARE pathway is a living tool to support health care workers visualize the current clinical and therapeutic recommendations to be considered in the care planning for patients with COVID-19. The COVID-19 CARE pathway is aligned with the eighth version of the WHO Therapeutics and COVID... more

External Link

Coronavirus disease (COVID-19) training: Online training
recommended

World Health Organization WHO (2022) C_WHO

access free courses in more than 60 languages

Download (139)

View PDF (182)

Assessment of COVID-19 Detection Laboratories, 31 March 2022

Government of Libya, World Health Organization (WHO) (2022) C_WHO

By end of March 2022: 42 COVID-19 detection laboratories were assessed in the 1st Quarter 2022. 23 (55%) Labs are reported fully functional, while 19 (45%) requires assistance to fully operate (i.e., medical supplies, equipment, maintenance, and staffing). 34 (89%) labs have RT-... more

Download (401)

View PDF (453)

Nutrition Curriculum: Basic and Advanced Modules Training Manual (Karen Version)

The Border Consortium (TBC), International Rescue Committee (2017) C1

The Border Consortium (TBC) developed a comprehensive Training of Trainers Nutrition Curriculum which includes 12 Modules (6 Basic and 6 Advanced topics). The Manual provides trainers with standardized methods and content to deliver nutrition training.
Original file: 20 MB

Download (120)

View PDF (141)

Interim Guidance on the Use of Rapid Antigen tests for COVID-19 Response
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C1

16 Dec. 2020 This document provides guidance to Ministries of Health (MOHs), laboratory personnel and implementing partners in African Union Member States on the application of rapid antigen tests to COVID-19 testing. The guidance serves as reference for policymakers, laboratory leads, implementing... more

Download (130)

View PDF (196)

WHO list of prequalified in vitro diagnostic products

World Health Organization (2017) C_WHO

Download (264)

View PDF (308)

Enhanced COVID-19 Surveillance at the Community Level in Africa

African Union; Africa CDC Centres for Disease Control and Prevention (2021) CC

The strategy recommends that AU Member States should enhance, where feasible, existing COVID-19 surveillance to include: Community-based surveillance to detect symptomatic cases early for treatment and to avert viral transmission; Sentinel surveillance in high-risk populations to detect ... more

Download (84)

View PDF (78)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Cadre de l'Assurance Qualité Test de Diagnostic Rapide de l'Antigene COV-2-SARS recommended

Infection Prevention and Control (IPC) Standard Operating Procedure (SOP) for Training/Meetings in the context of COVID-19 recommended

Coronavirus disease (COVID-19) training: Online training recommended

Interim Guidance on the Use of Rapid Antigen tests for COVID-19 Response recommended

Cadre de l'Assurance Qualité Test de Diagnostic Rapide de l'Antigene COV-2-SARS
recommended

Infection Prevention and Control (IPC) Standard Operating Procedure (SOP) for Training/Meetings in the context of COVID-19
recommended

Coronavirus disease (COVID-19) training: Online training
recommended

Interim Guidance on the Use of Rapid Antigen tests for COVID-19 Response
recommended